These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6698120)

  • 21. An NMR investigation of the binding of the anticancer drug actinomycin D to oligodeoxyribonucleotides with isolated 5'd(GC)3' binding sites.
    Jones RL; Scott EV; Zon G; Marzilli LG; Wilson WD
    Biochemistry; 1988 Aug; 27(16):6021-6. PubMed ID: 3191105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of actinomycin D to [d(ATCGAT)]2: NMR evidence of multiple complexes.
    Zhou N; James TL; Shafer RH
    Biochemistry; 1989 Jun; 28(12):5231-9. PubMed ID: 2548605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel molecular mechanism for actinomycin D activity as an oncogenic promoter G-quadruplex binder.
    Kang HJ; Park HJ
    Biochemistry; 2009 Aug; 48(31):7392-8. PubMed ID: 19496619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of actinomycin D to single-stranded DNA of sequence motifs d(TGTCT(n)G) and d(TGT(n)GTCT).
    Chen FM; Sha F; Chin KH; Chou SH
    Biophys J; 2003 Jan; 84(1):432-9. PubMed ID: 12524296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Actinomycin D binds strongly and dissociates slowly at the dGpdC site with flanking T/T mismatches.
    Liu C; Chen FM
    Biochemistry; 1996 Dec; 35(50):16346-53. PubMed ID: 8973210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of actinomycin D to constitutive heterochromatin in Microtus agrestis.
    Sieger M; Garweg G
    Naturwissenschaften; 1971 May; 58(5):271. PubMed ID: 5580888
    [No Abstract]   [Full Text] [Related]  

  • 27. Investigation of the drug binding properties and cytotoxicity of DNA-capped nanoparticles designed as delivery vehicles for the anticancer agents doxorubicin and actinomycin D.
    Alexander CM; Dabrowiak JC; Maye MM
    Bioconjug Chem; 2012 Oct; 23(10):2061-70. PubMed ID: 23043330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of multiple complexes between actinomycin D and a DNA hairpin: structural characterization by multinuclear NMR.
    Brown DR; Kurz M; Kearns DR; Hsu VL
    Biochemistry; 1994 Jan; 33(3):651-64. PubMed ID: 8292593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding specificities of actinomycin D to non-self-complementary -XGCY-tetranucleotide sequences.
    Chen FM
    Biochemistry; 1992 Jul; 31(27):6223-8. PubMed ID: 1627564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of actinomycin D with promoter element of c-met and its inhibitory effect on the expression of c-Met.
    Singhal G; Rajeswari MR
    J Biomol Struct Dyn; 2009 Apr; 26(5):625-36. PubMed ID: 19236112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2D NMR investigation of the binding of the anticancer drug actinomycin D to duplexed dATGCGCAT: conformational features of the unique 2:1 adduct.
    Scott EV; Zon G; Marzilli LG; Wilson WD
    Biochemistry; 1988 Oct; 27(20):7940-51. PubMed ID: 3207721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-Dose Actinomycin-D Induces Redistribution of Wild-Type and Mutated Nucleophosmin Followed by Cell Death in Leukemic Cells.
    Brodská B; Holoubek A; Otevřelová P; Kuželová K
    J Cell Biochem; 2016 Jun; 117(6):1319-29. PubMed ID: 26505272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fluorescence microscopic and autoradiographic analyses of the differential reaction of various regions of polytene chromosomes in Chironomus to prolonged exposure to 7-amino-actinomycin D and 3H-actinomycin D].
    Valeeva FS; Stepanova NG; Nikitin SM; Zhuze AL; Kinadze II
    Tsitologiia; 1984 Nov; 26(11):1255-61. PubMed ID: 6523572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Force spectroscopy reveals the DNA structural dynamics that govern the slow binding of Actinomycin D.
    Paramanathan T; Vladescu I; McCauley MJ; Rouzina I; Williams MC
    Nucleic Acids Res; 2012 Jun; 40(11):4925-32. PubMed ID: 22328730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Observation of an anomalously slow association kinetics in the binding of actinomycin D to d(CATGGCCATG).
    Chen FM
    Biochemistry; 1990 Aug; 29(33):7684-90. PubMed ID: 2271527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic and equilibrium binding studies of actinomycin D with some d(TGCA)-containing dodecamers.
    Chen FM
    Biochemistry; 1988 Mar; 27(6):1843-8. PubMed ID: 3378033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding specificities of actinomycin D to self-complementary tetranucleotide sequences -XGCY-.
    Chen FM
    Biochemistry; 1988 Aug; 27(17):6393-7. PubMed ID: 3219342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actinomycin D amplifies site-specific DNA cleavage induced by neocarzinostatin.
    Hiraku Y; Kawanishi S
    Biochem Biophys Res Commun; 1997 Oct; 239(1):134-8. PubMed ID: 9345283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of prednisolone on thymus lymphocytes. 1. Autoradiographic studies on 3 H-actinomycin D binding and 3 H-uridine incorporation.
    Darzynkiewicz Z; Andersson J
    Exp Cell Res; 1971 Jul; 67(1):39-48. PubMed ID: 5569202
    [No Abstract]   [Full Text] [Related]  

  • 40. Survival and functional recovery of primary cortical neurons exposed to actinomycin D.
    Lee SE; Lee GH
    Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):132-139. PubMed ID: 36332475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.